In light of the finding that neuroblastoma cells treated with DFMO compensate for a decrease in intracellular polyamines by augmenting polyamine uptake, we next assessed whether SLC3A2‐mediated polyamine uptake contributes to the DFMO‐induced increase in polyamine uptake [10, 24, 25]. This evidence concerns the gene SLC3A2 and neuroblastoma.